Mifeptristone (RU 486)
Mifepristone (RU 486; Mifeprex - Danco), an antiprogestin, has been approved by the FDA for termination of intrauterine pregnancies of 49 days or less. It is generally used with misoprostol (Cytotec - Searle), an E1 prostaglandin analog marketed in the USA only for prevention of gastric ulcers....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Mifeptristone (RU 486)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1091
Article Code: 1091a
Date: October 30, 2000
Volume: 42
Pages: 101-102
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1091
Article Code: 1091a
Date: October 30, 2000
Volume: 42
Pages: 101-102
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)